Navidea Biopharmaceuticals (NAVB) to Co-Sponsor Alzheimer’s Imaging Consortium at Alzheimer’s Association International Conference
7/11/2013 7:16:36 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it will co-sponsor the 2013 Alzheimer’s Imaging Consortium on July 13, 2013. The full-day event features leading international experts and will be chaired by Drs. Gil Rabinovici, University of California, San Francisco, United States, and Christopher Rowe, Austin Health, Melbourne, Australia. The Consortium is part of the Alzheimer’s Association International Conference (AAIC), being held July 13 – 18, 2013, in Boston, Mass. The annual AAIC is attended by leaders in dementia research and medicine from around the globe, and is the largest conference of its kind in the world.
Help employers find you! Check out all the jobs and post your resume.